Publication | Closed Access
IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody
108
Citations
14
References
2018
Year
IdeS may represent a groundbreaking new method of desensitization for patients who otherwise might have no hope for receiving a lifesaving transplant.
| Year | Citations | |
|---|---|---|
Page 1
Page 1